Picture of Vivesto AB logo

VIVE Vivesto AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Vivesto AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-129-355-132-42-34.4
Depreciation
Amortisation
Non-Cash Items0
Other Non-Cash Items
Changes in Working Capital-45.818.46.05-10.2-1.38
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-146-80.5-68.7-47.2-34
Capital Expenditures-34.3-0.277-0.6590-9.85
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items153-4564.443.431.7
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities119-45.363.743.421.8
Financing Cash Flow Items-16.40
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5.81129013
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-32.21.55-5.18-3.511.25